ACUILIX 20 mg/12.5 mg, film-coated tablet scored 28 tablets
Active ingredients: Quinapril hydrochloride, HYDROCHLOROTHIAZIDE, Quinapril
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ACUILIX 20 mg/12,5 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC aluminium polyamide de 28 comprimé(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 9 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68337593CIP73364079CIP133400933640798Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYDROCHLOROTHIAZIDEcomprimé | 12,5 mg · un comprimé | SA |
| CHLORHYDRATE DE QUINAPRILcomprimé | 21,7 mg · un comprimé | SA |
| QUINAPRIL BASEcomprimé | 20 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.